K2M Group (KTWO) Lowered to “Hold” at BidaskClub

BidaskClub lowered shares of K2M Group (NASDAQ:KTWO) from a buy rating to a hold rating in a research report released on Wednesday morning.

A number of other analysts have also recently weighed in on KTWO. Cowen set a $28.00 price objective on shares of K2M Group and gave the stock a buy rating in a report on Thursday, August 17th. William Blair reaffirmed an outperform rating on shares of K2M Group in a report on Tuesday, October 10th. Piper Jaffray Companies reaffirmed an overweight rating and issued a $28.00 price objective on shares of K2M Group in a report on Tuesday, October 10th. Oppenheimer set a $24.00 price objective on shares of K2M Group and gave the stock a buy rating in a report on Wednesday, October 18th. Finally, JMP Securities reaffirmed an outperform rating and issued a $25.00 price objective (down previously from $30.00) on shares of K2M Group in a report on Tuesday, October 10th. One research analyst has rated the stock with a sell rating, two have given a hold rating and ten have issued a buy rating to the stock. The stock has a consensus rating of Buy and a consensus price target of $24.40.

Shares of K2M Group (NASDAQ:KTWO) opened at $17.19 on Wednesday. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.67 and a current ratio of 3.06. K2M Group has a twelve month low of $16.44 and a twelve month high of $25.99.

K2M Group (NASDAQ:KTWO) last released its quarterly earnings data on Wednesday, November 1st. The medical device company reported ($0.20) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.19) by ($0.01). K2M Group had a negative return on equity of 16.02% and a negative net margin of 16.22%. The firm had revenue of $62.65 million during the quarter, compared to analyst estimates of $62.69 million. During the same period last year, the business earned ($0.19) EPS. The firm’s revenue was up 5.6% on a year-over-year basis. analysts forecast that K2M Group will post -0.86 EPS for the current year.

A number of institutional investors and hedge funds have recently made changes to their positions in KTWO. Cubist Systematic Strategies LLC grew its position in K2M Group by 7,765.0% in the 3rd quarter. Cubist Systematic Strategies LLC now owns 4,719 shares of the medical device company’s stock valued at $100,000 after buying an additional 4,659 shares in the last quarter. Rockefeller Financial Services Inc. bought a new position in K2M Group in the 3rd quarter valued at about $105,000. BNP Paribas Arbitrage SA grew its position in K2M Group by 5,175.3% in the 2nd quarter. BNP Paribas Arbitrage SA now owns 4,484 shares of the medical device company’s stock valued at $109,000 after buying an additional 4,399 shares in the last quarter. Legal & General Group Plc grew its position in K2M Group by 9.1% in the 1st quarter. Legal & General Group Plc now owns 6,763 shares of the medical device company’s stock valued at $138,000 after buying an additional 564 shares in the last quarter. Finally, Dorsey & Whitney Trust CO LLC bought a new position in K2M Group in the 2nd quarter valued at about $211,000. Hedge funds and other institutional investors own 99.16% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This news story was first published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this news story on another website, it was illegally stolen and reposted in violation of United States & international trademark and copyright law. The legal version of this news story can be viewed at https://ledgergazette.com/2017/12/10/k2m-group-ktwo-lowered-to-hold-at-bidaskclub.html.

K2M Group Company Profile

K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.

Analyst Recommendations for K2M Group (NASDAQ:KTWO)

Receive News & Ratings for K2M Group Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply